Results 241 to 250 of about 665,029 (266)
Some of the next articles are maybe not open access.

Oxcarbazepine: Anticonvulsant profile and safety

Drugs of Today, 2001
Oxcarbazepine is a molecule chemically related to carbamazepine that shares most of the pharmacological and therapeutic effects of carbamazepine while displaying a more favorable profile regarding tolerability and drug-drug interactions. In contrast to carbamazepine, oxcarbazepine is metabolized through cytochrome P450-independent reductases, and is ...
openaire   +2 more sources

Safety Profile of Sublingual Immunotherapy

Treatments in Respiratory Medicine, 2006
Sublingual immunotherapy (SLIT) was proposed for clinical practice about 20 years ago with the main aim of improving the safety and avoiding the adverse effects of traditional treatment for allergic airways disease. To date, 32 randomized controlled trials and 6 postmarketing surveys have been published that provide a robust documentation of the safety
PASSALACQUA, GIOVANNI   +3 more
openaire   +3 more sources

Aripiprazole: profile on efficacy and safety

Expert Opinion on Pharmacotherapy, 2002
Aripiprazole (Abilitat, Bristol-Myers Squibb) is the most recent addition to the new class of atypical antipsychotic medications, following the release of clozapine, risperidone, olanzapine, quetiapine and ziprasidone. Aripiprazole exhibits typical antagonism at dopamine (D2) receptors in the mesolimbic pathway, as well as having unique partial agonist
Paul J, Goodnick, Jason M, Jerry
openaire   +2 more sources

Oxaliplatin-safety profile: neurotoxicity

Seminars in Oncology, 2003
Oxaliplatin has become an integral part of various chemotherapy protocols, and in advanced colorectal cancer in particular. While oxaliplatin has only mild hematologic and gastrointestinal side effects, its dose-limiting toxicity is a cumulative sensory neurotoxicity that resembles that of cisplatin with the important difference of a more rapid and ...
openaire   +2 more sources

Safety and toxicity profile of aztreonam

The Pediatric Infectious Disease Journal, 1989
Aztreonam is the first monocyclic beta-lactam antibiotic released for clinical use. Extensive toxicity and safety data for aztreonam in animals, healthy volunteers and adult patients have been accumulated previously; recently these studies have been extended to children. Overall the incidence of adverse clinical reactions caused by aztreonam is similar
openaire   +2 more sources

Encainide?An updated safety profile

Cardiovascular Drugs and Therapy, 1990
The safety of encainide has been evaluated using retrospective analyses of the Bristol-Myers Supraventricular and Ventricular Arrhythmias data base and of the Post-Marketing Adverse Experience Report data and prospective analyses of the Cardiac Arrhythmia Suppression Trial (CAST), the Cardiac Arrhythmia Pilot Study (CAPS), and the Ventricular ...
openaire   +2 more sources

Safety Profile

Obstetrics & Gynecology, 2001
James A. Simon   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy